https://www.iposight.com/news/a-rejtett-asvanykincs-termelo/2026-04-27T14:27:44+00:00https://www.iposight.com/news/a-rejtett-egi-versenyzo/2026-04-27T14:17:16+00:00https://www.iposight.com/news/high-growth-potential-or-hype-driven-overvaluation/2026-04-10T11:04:31+00:00https://www.iposight.com/news/swmr-ai-drone-warfare-disruptor-or-one-of-the-most-overhyped-ipos-of-2026/2026-04-15T09:20:35+00:00https://www.iposight.com/news/veradermics-mane-the-next-breakout-biotech-or-an-ipo-running-too-far-too-fast/2026-04-22T09:38:37+00:00https://www.iposight.com/news/fluidstack-the-ai-infrastructure-startup-quietly-powering-the-next-wave-of-artificial-intelligence/2026-04-22T13:05:30+00:00https://www.iposight.com/news/cardinal-infrastructure-cdnl-a-real-business-behind-the-ipo-hype-but-is-the-stock-already-pricing-in-perfection/2026-04-24T12:34:22+00:00https://www.iposight.com/news/candela-the-swedish-startup-trying-to-reinvent-water-tr/2026-04-24T13:31:47+00:00https://www.iposight.com/news/northwesterns-artificial-neuron-breakthrough-could-transform-neurotechnology-but-commercial-reality-is-still-years-away/2026-04-27T08:34:53+00:00https://www.iposight.com/news/flowco-floc-a-quiet-energy-infrastructure-compounder-or-an-overlooked-oilfield-stock-facing-a-valuation-ceiling/2026-04-28T15:17:13+00:00https://www.iposight.com/news/atmos-space-cargo-the-european-startup-trying-to-build-the-missing-layer-of-the-space-economy/2026-04-28T16:57:13+00:00https://www.iposight.com/news/avalyn-pharma-avln-a-high-risk-biotech-bet-on-breakthrough-lung-therapies-or-another-cash-burning-clinical-story/2026-05-04T15:19:43+00:00https://www.iposight.com/news/rare-earths-americas-rea-a-critical-minerals-ipo-at-the-center-of-a-geopolitical-supercycle-breakthrough-opportunity-or-early-stage-speculation/2026-05-06T18:15:29+00:00https://www.iposight.com/news/veradermics-mane-breakthrough-biotech-or-bubble-territory-after-the-explosive-rally-600/2026-05-08T14:40:04+00:00https://www.iposight.com/news/regentis-biomaterials-rgnt-deep-value-biotech-opportunity-or-a-falling-knife-after-ipo-collapse/2026-05-09T14:54:13+00:00https://www.iposight.com/news/metaphore-biotechnologies-the-ai-driven-biotech-startup-trying-to-redesign-human-proteins/2026-05-11T07:56:23+00:00https://www.iposight.com/news/venture-global-vg-one-of-the-most-tradable-energy-ipos-on-the-market/2026-05-11T11:21:53+00:00https://www.iposight.com/news/legence-lgn-260-since-ipo-ai-infrastructure-winner/2026-05-13T19:07:42+00:00https://www.iposight.com/news/hemab-therapeutics-coag-rare-disease-breakthrough-story/2026-05-15T12:12:42+00:00https://www.iposight.com/news/the-2025-2026-ipo-washout-why-38-new-listings-collapsed-and-which-ones-still-deserve-a-second-look/2026-05-16T10:05:29+00:00https://www.iposight.com/news/fervo-energy-frvo-the-hottest-energy-ipo-of-2026-real-geothermal-revolution/2026-05-18T09:41:23+00:00https://www.iposight.com/news/beta-technologies-beta-undervalued-evtol-pioneer/2026-05-22T17:45:52+00:00https://www.iposight.com/news/cerebras-systems-cbrs-the-ai-chip-challenger-that-wants-to-break-nvidias-dominance/2026-05-27T13:35:34+00:00https://www.iposight.com/news/amass-brands-amss-undervalued-future-beverage-disruptor-or-failed-ipo-story/2026-05-28T15:29:06+00:00https://www.iposight.com/news/the-evtol-reality-check-which-electric-aviation-company-could-actually-win/2026-05-29T08:02:56+00:00https://www.iposight.com/news/conexeu-sciences-cnxu-the-early-stage-regenerative-medicine-moonshot/2026-06-01T12:26:38+00:00